Thus, it is tempting to speculate that primary immunodeficiences, resulting from ITK and CD70 mutations, more prominently predispose for loss of NKT cell-mediated innate immune control and thereby favor uncontrolled EBV latency II, as in HL. The gene discussed is ITK; the disease is Hodgkins lymphoma.